220 related articles for article (PubMed ID: 34873031)
41. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
Waldhauer I; Steinle A
Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567
[TBL] [Abstract][Full Text] [Related]
42. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
[TBL] [Abstract][Full Text] [Related]
43. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
44. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
[TBL] [Abstract][Full Text] [Related]
45. NKG2D/Ligand dysregulation and functional alteration of innate immunity cell populations in pediatric IBD.
La Scaleia R; Stoppacciaro A; Oliva S; Morrone S; Di Nardo G; Santoni A; Cucchiara S; Palmieri G
Inflamm Bowel Dis; 2012 Oct; 18(10):1910-22. PubMed ID: 22294522
[TBL] [Abstract][Full Text] [Related]
46. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
[TBL] [Abstract][Full Text] [Related]
47. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.
Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D
Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194
[TBL] [Abstract][Full Text] [Related]
48. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
Schrama D; Terheyden P; Otto K; Kämmerer U; Bröcker EB; Lühder F; Cosman D; Andersen MH; Becker JC
Eur J Immunol; 2006 Jan; 36(1):65-72. PubMed ID: 16342232
[TBL] [Abstract][Full Text] [Related]
49. Mutual activation of CD4+ T cells and monocytes mediated by NKG2D-MIC interaction requires IFN-gamma production in systemic lupus erythematosus.
Yang D; Wang H; Ni B; He Y; Li J; Tang Y; Fu X; Wang Q; Xu G; Li K; Yang Z; Wu Y
Mol Immunol; 2009 Apr; 46(7):1432-42. PubMed ID: 19200602
[TBL] [Abstract][Full Text] [Related]
50. UL16 binding proteins.
Cao W; He W
Immunobiology; 2004; 209(3):283-90. PubMed ID: 15518340
[TBL] [Abstract][Full Text] [Related]
51. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.
Nice TJ; Coscoy L; Raulet DH
J Exp Med; 2009 Feb; 206(2):287-98. PubMed ID: 19171762
[TBL] [Abstract][Full Text] [Related]
52. [Expression and clinical significance of CD8+natural killer T cell stimulatory receptor NKG2D in peripheral blood of lung cancer patients].
Cheng N; Han F; Wang Y; Mai X; Su W
Zhongguo Fei Ai Za Zhi; 2010 Oct; 13(10):962-7. PubMed ID: 20959069
[TBL] [Abstract][Full Text] [Related]
53. A disease-linked
Zuo J; Willcox CR; Mohammed F; Davey M; Hunter S; Khan K; Antoun A; Katakia P; Croudace J; Inman C; Parry H; Briggs D; Malladi R; Willcox BE; Moss P
Sci Signal; 2017 May; 10(481):. PubMed ID: 28559451
[TBL] [Abstract][Full Text] [Related]
54. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
[TBL] [Abstract][Full Text] [Related]
55. Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.
Pittet CL; Newcombe J; Prat A; Arbour N
J Neuroinflammation; 2011 Nov; 8():155. PubMed ID: 22067141
[TBL] [Abstract][Full Text] [Related]
56. NKG2D: A versatile player in the immune system.
Jelenčić V; Lenartić M; Wensveen FM; Polić B
Immunol Lett; 2017 Sep; 189():48-53. PubMed ID: 28414183
[TBL] [Abstract][Full Text] [Related]
57. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
[TBL] [Abstract][Full Text] [Related]
58. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
Whitman E; Barber A
Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
[TBL] [Abstract][Full Text] [Related]
59. Increased HLA-E expression in white matter lesions in multiple sclerosis.
Durrenberger PF; Webb LV; Sim MJ; Nicholas RS; Altmann DM; Boyton RJ
Immunology; 2012 Dec; 137(4):317-25. PubMed ID: 23039207
[TBL] [Abstract][Full Text] [Related]
60. Heat-killed Helicobacter pylori upregulates NKG2D ligands expression on gastric adenocarcinoma cells via Toll-like receptor 4.
Hernández C; Toledo-Stuardo K; García-González P; Garrido-Tapia M; Kramm K; Rodríguez-Siza JA; Hermoso M; Ribeiro CH; Molina MC
Helicobacter; 2021 Aug; 26(4):e12812. PubMed ID: 33928707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
